Dichotomous outcomes vs. survival regression models for identification of predictors of mortality among patients with severe acute respiratory illness during COVID-19 pandemicsFRONTIERS IN PUBLIC HEALTHIF3.42023-12-060OAAI
Comparing the activity of propolis-loaded nanoparticles or hydroethanolic extract on cytokine production by peripheral blood mononuclear cellsPHYTOTHERAPY RESEARCHIF6.32023-06-061PRE
Propolis consumption by asymptomatic HIV-individuals: Better redox state? A prospective, randomized, double-blind, placebo-controlled trialBIOMEDICINE & PHARMACOTHERAPYIF7.52023-06-012OAAI
Effectiveness of the Fiocruz recombinant ChadOx1-nCoV19 against variants of SARS-CoV-2 in the Municipality of Botucatu-SPFRONTIERS IN PUBLIC HEALTHIF3.42022-10-135OAAI
Brazilian red propolis exerts a cytotoxic action against prostate cancer cells and upregulates human monocyte functionsPHYTOTHERAPY RESEARCHIF6.32022-09-089PRE
Brazilian green propolis: A novel tool to improve the cytotoxic and immunomodulatory action of docetaxel on MCF-7 breast cancer cells and on women monocytePHYTOTHERAPY RESEARCHIF6.32021-12-0410PREAI
Propolis increases Foxp3 expression and lymphocyte proliferation in HIV-infected people: A randomized, double blind, parallel-group and placebo-controlled study蜂胶增加HIV感染者的Foxp3表达和淋巴细胞增殖: 一项随机,双盲,平行组和安慰剂对照研究BIOMEDICINE & PHARMACOTHERAPYIF7.52021-10-0114OAAI
Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4+ T Cell RestorationJOURNAL OF IMMUNOLOGY RESEARCHIF3.62018-01-015OAAI
The Initial Months of Antiretroviral Therapy and Its Influence on AGEs, HMGB1, and sRAGE Levels in Asymptomatic HIV-Infected IndividualsMEDIATORS OF INFLAMMATIONIF4.22016-01-018OAAI